BridgeBio Oncology to go public in $450 million SPAC and PIPE deal $BBIO https://t.co/WPSiQ46nnW via @SFBusinessTimes

Rich Law 🚜--🇺🇦@drrichjlaw

5 months ago

BridgeBio oncology spinout to go public via combination with Helix Acquisition Corp. II SPAC, to create $BBOT worth $949M. https://t.co/argdiRpOuV $BBIO

This South San Francisco company would be the first Bay Area biotech company to go public this year, proving that the SPAC isn't dead. https://t.co/x1pqh2xH5I